日本低FODMAP食推進会

コロンビア共和国は、かつてスペインの植民地だったためか、国民の人種の半数以上が白人とラテンアメリカの先住民（インディオ）との混血であるメスティーソである。

そのコロンビアでも過敏性腸症候群に対して低FODMAP食が有効であることが報告された。

効果は年齢、性別、体格、経済状態に無関係であった。

https://www.ncbi.nlm.nih.gov/pubmed/29809329

Diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols, and quality of life in patients with irritable bowel syndrome in Colombia

Yepes IJ1, Múnera MN, Martelo C.

Author information

Departamento de Investigaciones, Facultad de Medicina, Universidad de Cartagena, Cartagena, Colombia Pharos, Centro de Investigaciones Biomédicas de la Costa, Cartagena, Colombia.

Abstract

INTRODUCTION:

A growing body of evidence has pointed out the effectiveness of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) in patients with irritable bowel syndrome. However, there are no local studies to estimate the effects of this strategy on the symptoms and the health-related quality of life in these patients in Colombia or Latin America.

OBJECTIVE:

To determine the effect of a diet low in FODMAP on the quality of life and the severity of symptoms in patients with irritable bowel syndrome in Colombia.

MATERIALS AND METHODS:

We collected clinical and demographic information of all patients at the time of inclusion. Immediately afterwards, a trained interviewer applied the IBS-QoL survey to estimate the quality of life of patients. Then, we evaluated the intensity of the symptoms using an analogue visual scale, before and after the diet low in FODMAP.

RESULTS:

We included 50 subjects in the final analysis. We observed an increase in all the IBS-QoL scales (average increase in overall summary: 14.7 points, 95% CI: 9.4 to 20.1; p<0.001) and a significant reduction in all symptoms (-19.8 mm; 95% CI: 23.4 mm 16.2 mm; p<0.001). Sex, age, body mass index, socioeconomic status and the health care provider were not associated with the improvement in the health-related quality of life.

CONCLUSION:

A low diet in FODMAP reduced symptoms and improved quality of life in Colombian patients with irritable bowel syndrome. Controlled studies taking into account other factors linked to the severity of irritable bowel syndrome are required.